Related Experiment Video
Updated: Jun 10, 2026
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Power calculation for case-cohort studies with nonrare events
1Department of Biostatistics, University of North Carolina at Chapel Hill, North Carolina 27599-7420, USA.
Biometrics
|July 5, 2007
Summary
The generalized case-cohort design efficiently studies non-rare events by sampling fractions of events. This approach offers a valid statistical test for comparing hazard functions with minimal efficiency loss.
Area of Science:
- Epidemiology
- Biostatistics
- Statistical Genetics
Background:
- Case-cohort studies are valuable for rare disease epidemiology.
- Traditional case-cohort designs sample all events for rare outcomes.
- Non-rare events necessitate alternative sampling strategies.
Purpose of the Study:
- To develop a generalized case-cohort design for non-rare events.
- To provide a valid statistical test for comparing hazard functions in this design.
- To assess the power and efficiency of the generalized design.
Main Methods:
- Proposed a generalized case-cohort design allowing fractional event sampling.
- Developed a valid test statistic for comparing hazard functions between two samples.
- Derived a method for calculating statistical power under the generalized design.
Main Results:
- The proposed test statistic is valid for comparing hazard functions in the generalized case-cohort design.
- The method for power calculation is provided.
- Numerical analysis indicates very low efficiency loss when sampling only a fraction of non-rare events.
Conclusions:
- The generalized case-cohort design is an efficient alternative for studying non-rare events.
- The developed statistical methods support its application in epidemiologic research.
- This approach offers a practical solution for risk-factor assessment in broader study populations.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...